This inventor holds 1 USPTO granted patent and 1 published patent application, plus 4 CIPO patents. Top assignee: I-Lumen Scientific, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael A Moffitt: Innovator in Ophthalmic Therapy
Introduction
Michael A Moffitt is an accomplished inventor based in Delano, MN (US). He has made significant contributions to the field of ophthalmic therapy, particularly through his innovative patent that focuses on microcurrent therapy.
Latest Patents
Moffitt holds a patent titled "Systems and methods to manage microcurrent therapy dose." This patent encompasses methods, apparatuses, and systems designed for ophthalmic therapy. The technology involves determining electrical therapy delivery characteristics through a testing or calibration phase, taking into account a patient's known disease state. By utilizing expected values for phosphene thresholds in the patient's eye, the system measures the relationship between therapy output from electrodes near the eye and the energy received at the eye, such as through corneal measurements. The outcome may include therapy delivery targets and estimates of the patient's disease state.
Career Highlights
Moffitt's career is marked by his dedication to advancing medical technology. His work at I-Lumen Scientific, Inc. has positioned him as a key player in the development of innovative therapeutic solutions. His patent reflects his commitment to improving patient outcomes through precise and effective treatment methods.
Collaborations
Moffitt collaborates with notable colleagues, including James R Chiapetta and Que T Doan. Their combined expertise contributes to the advancement of technologies in the field of ophthalmic therapy.
Conclusion
Michael A Moffitt's contributions to ophthalmic therapy through his innovative patent demonstrate his commitment to enhancing medical treatments. His work continues to influence the field and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile